Insider Transactions last 24 months for Crinetics Pharmaceuticals, Inc.  -  NSDQ: CRNX

 
Transactions
All Buy Sell Option Exercise
Filer's Name
Relationship/
Title
Trans.
Date
Trans. Type
Ownership Type
Security Type
Shares
Price
Trans.
Value
Total Shares Owned
Pizzuti DanaChief Med and Dev Officer09/02/2025DSDirectCOM5,000$32.10$160,500.0096,270
Pizzuti DanaChief Med and Dev Officer09/02/2025AMDirectCOM5,000$16.89$84,450.00101,270
Pizzuti DanaChief Med and Dev Officer08/22/2025DSDirectCOM30,000$30.43$912,900.0066,270
Pizzuti DanaChief Med and Dev Officer08/22/2025AMDirectCOM30,000$16.89$506,700.0096,270
Pizzuti DanaChief Med and Dev Officer08/20/2025DSDirectCOM6,492$29.18$189,436.5666,270
Betz Stephen F.Chief Scientific Officer06/12/2025DSDirectCOM97,483$32.23$3,141,877.0999,713
Betz Stephen F.Chief Scientific Officer06/12/2025AMDirectCOM16,645$9.28$154,465.60197,196
Betz Stephen F.Chief Scientific Officer06/12/2025AMDirectCOM71,525$1.91$136,612.75180,551
Wierenga WendallDirector06/11/2025AADirectCOM6,900$0.00$0.00116,146
Nichols WestonDirector06/11/2025AADirectCOM6,900$0.00$0.0016,300
Bedrosian Camille LDirector06/11/2025AADirectCOM6,900$0.00$0.0016,300
Fust Matthew KDirector06/11/2025AADirectCOM6,900$0.00$0.0028,836
Okey StephanieDirector06/11/2025AADirectCOM6,900$0.00$0.0016,300
Vivaldi Coelho RogerioDirector06/11/2025AADirectCOM6,900$0.00$0.0021,300
Deardorf CarenDirector06/11/2025AADirectCOM6,900$0.00$0.0016,300
Struthers Richard ScottPresident & CEO05/14/2025AGIndirectCOM90,400$0.00$0.00661,205
Struthers Richard ScottPresident & CEO05/14/2025DGDirectCOM90,400$0.00$0.00320,017
Struthers Richard ScottPresident & CEO04/02/2025AMDirectCOM81,270$1.91$155,225.70410,417
Struthers Richard ScottPresident & CEO03/19/2025DSDirectCOM875$34.83$30,476.25329,147
Struthers Richard ScottPresident & CEO03/19/2025DSDirectCOM16,463$34.17$562,540.71330,022
Betz Stephen F.Chief Scientific Officer03/19/2025DSDirectCOM291$34.83$10,135.53108,588
Betz Stephen F.Chief Scientific Officer03/19/2025DSDirectCOM5,479$34.17$187,217.43108,879
Knight Jeff E.Chief Operating Officer03/19/2025DSDirectCOM361$34.83$12,573.6387,491
Knight Jeff E.Chief Operating Officer03/19/2025DSDirectCOM6,801$34.17$232,390.1787,852
Pizzuti DanaChief Med and Dev Officer03/19/2025DSDirectCOM127$34.83$4,423.4172,233
1   2  3  4  5  6  Next Last  You are at page 1 of 6 pages
Transaction Type Key
First letter: A = Acquired, D = Disposed
Second letter:
A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust 		Export Table Data to Excel Send to Excel